EIF3E
Eukaryotic translation initiation factor 3 subunit E
Also known as: eIF3-p48, EIF3E_HUMAN, EIF3S6, INT6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P60228
- Gene
- EIF3E
- Ensembl
- ENSG00000104408
- Chromosome
- 8
- Canonical length
- 445 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables RNA binding activity and cadherin binding activity. Contributes to translation initiation factor activity. Involved in nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; positive regulation of translation; and translational initiation. Located in PML body and cytosol. Part of eukaryotic translation initiation factor 3 complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
445 residues, UniProt reviewed canonical sequence.
>P60228|EIF3E
1 MAEYDLTTRI AHFLDRHLVF PLLEFLSVKE IYNEKELLQG KLDLLSDTNM VDFAMDVYKN
61 LYSDDIPHAL REKRTTVVAQ LKQLQAETEP IVKMFEDPET TRQMQSTRDG RMLFDYLADK
121 HGFRQEYLDT LYRYAKFQYE CGNYSGAAEY LYFFRVLVPA TDRNALSSLW GKLASEILMQ
181 NWDAAMEDLT RLKETIDNNS VSSPLQSLQQ RTWLIHWSLF VFFNHPKGRD NIIDLFLYQP
241 QYLNAIQTMC PHILRYLTTA VITNKDVRKR RQVLKDLVKV IQQESYTYKD PITEFVECLY
301 VNFDFDGAQK KLRECESVLV NDFFLVACLE DFIENARLFI FETFCRIHQC ISINMLADKL
361 NMTPEEAERW IVNLIRNARL DAKIDSKLGH VVMGNNAVSP YQQVIEKTKS LSFRSQMLAM
421 NIEKKLNQNS RSEAPNWATQ DSGFYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF3E can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 391 nTPM
Expression across tissuesHPA
Tissue
- breast: 391 nTPM
- pancreas: 382 nTPM
- ovary: 349 nTPM
- cervix: 302 nTPM
- thymus: 264 nTPM
- bone marrow: 237 nTPM
Single-cell type
- decidual stromal cells: 1,314 nCPM
- esophageal apical cells: 1,014 nCPM
- gastric progenitor cells: 932 nCPM
- esophageal basal cells: 927 nCPM
- migrating cytotrophoblasts: 916 nCPM
- esophageal suprabasal cells: 912 nCPM
Immune cell
- total PBMC: 318 nTPM
- naive CD4 T-cell: 302 nTPM
- naive CD8 T-cell: 227 nTPM
- myeloid DC: 219 nTPM
- memory B-cell: 215 nTPM
- memory CD4 T-cell: 206 nTPM
Brain region
- cerebellum: 53 nTPM
- white matter: 50 nTPM
- choroid plexus: 49 nTPM
- medulla oblongata: 48 nTPM
- hypothalamus: 46 nTPM
- midbrain: 44 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 3.13
- DepMap mean gene effect
- -1.34
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- formation of cytoplasmic translation initiation complex
- negative regulation of translational initiation
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
- positive regulation of translation
- regulation of translational initiation
- translational initiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Proteasome component (PCI) domain
- Winged helix DNA-binding domain superfamily
- PCI domain
- Eukaryotic translation initiation factor 3 subunit E
- Eukaryotic translation initiation factor 3 subunit E, N-terminal
- eIF3 subunit 6 N terminal domain
- Eukaryotic translation initiation factor 3 subunit E, C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF3E in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF3E as an antibody target. Whether an autoantibody or antibody against EIF3E could matter depends on whether native EIF3E is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF3E is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EIF3E as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...